- •AA amyloidosis epidemiology is evolving with a decrease of cases caused by inflammatory rheumatism.
- •Infections are now the most frequent cause of death of patients suffering from AA amyloidosis.
- •Several factors are associated with the mortality in AA amyloidosis, such as the cause of the amyloidosis, or the presence of a nephrotic syndrome.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- AA amyloidosis: pathogenesis and targeted therapy.Annu Rev Pathol. 2015; 10: 321-344
- Natural history and outcome in systemic AA amyloidosis.N Engl J Med. 2007; 356: 2361-2371
- Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.Amyloid. 2017; 24: 162-166
- AA amyloidosis is an emerging cause of nephropathy in obese patients.Eur J Intern Med. 2017; 39: e18-e20
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.Am J Hematol. 2005; 79: 319-328
Modern Applied Statistics with S, 4th ed [Internet]. [cited 2019 Nov 21]. Available from: http://www.stats.ox.ac.uk/pub/MASS4/.
- Global cardiovascular and renal outcomes of reduced GFR.J Am Soc Nephrol JASN. 2017; 28: 2167-2179
- Secondary, AA, amyloidosis.Rheum Dis Clin North Am. 2018; 44: 585-603
- Prognostication of survival and progression to dialysis in AA amyloidosis.Amyloid. 2017; 24: 136-137
- Risk adjustment in outcome assessment: the Charlson comorbidity index.Methods Inf Med. 1993; 32: 382-387